January 16, 2017
2017 is promising to be a pivotal year as CRISPR/Cas9 and CAR-T head toward critical milestones. In the coming months, the first therapy based on CAR-T will […]
January 16, 2017
In 2016, the FDA approved 22 new drugs, compared with 45 in 2015 and 41 in 2014. A slowdown in applications is partly to blame. The […]
January 16, 2017
The 21st Century Cures Act is a new law signed by President Obama that promises to allocate around $6B for funding medical research, the fight against cancer, […]
January 16, 2017
Featuring CEO Interview with Elizabeth G. Posillico, Ph.D., President & CEO, Elusys Therapeutics Inc. Your Issue of Ashton Tweed Connection Vol. 4 No. 1 is Here! Our […]
January 26, 2017
2016’s Fierce 15 are redefining what it means to be a medical device. If they’re not making big bets on new technologies, they’re reimagining existing ones. […]
February 1, 2017
February 2, 2017
After a slow year for new drug approvals with the FDA only approving 22 meds in 2016, we are looking forward to how drugmakers do in 2017. […]
February 16, 2017
The patent fight over the gene-editing technique CRISPR has a winner—the Broad Institute of Cambridge, MA. The battle began when the University of California, Berkeley challenged a […]
February 27, 2017
Featuring CEO Interview with Cynthia Schwalm, EVP, North America Commercial Operations, Ipsen Your Issue of Ashton Tweed Connection Vol. 4 No. 2 is Here! Our Site Contact […]